Thermo Fisher Scientific Free Cash Flow 2010-2025 | TMO
Thermo Fisher Scientific annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Thermo Fisher Scientific free cash flow for the quarter ending March 31, 2025 was 373.00, a year-over-year.
- Thermo Fisher Scientific free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
- Thermo Fisher Scientific annual free cash flow for 2024 was $7.324B, a 4.42% increase from 2023.
- Thermo Fisher Scientific annual free cash flow for 2023 was $7.014B, a 1.14% increase from 2022.
- Thermo Fisher Scientific annual free cash flow for 2022 was $6.935B, a 1.85% increase from 2021.
| Thermo Fisher Scientific Annual Free Cash Flow | |
|---|---|
| 2024 | 7,324.00 |
| 2023 | 7,014.00 |
| 2022 | 6,935.00 |
| 2021 | 6,809.00 |
| 2020 | 6,823.00 |
| 2019 | 4,083.00 |
| 2018 | 3,835.00 |
| 2017 | 3,504.00 |
| 2016 | 2,840.00 |
| 2015 | 2,537.00 |
| 2014 | 2,241.30 |
| 2013 | 1,749.00 |
| 2012 | 1,737.20 |
| 2011 | 1,438.30 |
| 2010 | 1,262.60 |
| 2009 | 1,472.60 |
| Thermo Fisher Scientific Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | 373.00 |
| 2024-12-31 | 7,324.00 |
| 2024-09-30 | 4,497.00 |
| 2024-06-30 | 2,583.00 |
| 2024-03-31 | 908.00 |
| 2023-12-31 | 7,014.00 |
| 2023-09-30 | 3,685.00 |
| 2023-06-30 | 1,537.00 |
| 2023-03-31 | 277.00 |
| 2022-12-31 | 6,935.00 |
| 2022-09-30 | 3,992.00 |
| 2022-06-30 | 2,598.00 |
| 2022-03-31 | 1,564.00 |
| 2021-12-31 | 6,809.00 |
| 2021-09-30 | 5,172.00 |
| 2021-06-30 | 3,042.00 |
| 2021-03-31 | 1,355.00 |
| 2020-12-31 | 6,823.00 |
| 2020-09-30 | 4,069.00 |
| 2020-06-30 | 1,726.00 |
| 2020-03-31 | 107.00 |
| 2019-12-31 | 4,083.00 |
| 2019-09-30 | 2,441.00 |
| 2019-06-30 | 1,534.00 |
| 2019-03-31 | 454.00 |
| 2018-12-31 | 3,835.00 |
| 2018-09-30 | 2,274.00 |
| 2018-06-30 | 1,224.00 |
| 2018-03-31 | -38.00 |
| 2017-12-31 | 3,504.00 |
| 2017-09-30 | 1,850.00 |
| 2017-06-30 | 1,031.00 |
| 2017-03-31 | 269.00 |
| 2016-12-31 | 2,840.00 |
| 2016-09-30 | 1,764.90 |
| 2016-06-30 | 1,040.10 |
| 2016-03-31 | 225.60 |
| 2015-12-31 | 2,537.00 |
| 2015-09-30 | 1,302.80 |
| 2015-06-30 | 658.60 |
| 2015-03-31 | -16.60 |
| 2014-12-31 | 2,241.30 |
| 2014-09-30 | 1,414.70 |
| 2014-06-30 | 822.40 |
| 2014-03-31 | -0.10 |
| 2013-12-31 | 1,749.00 |
| 2013-09-30 | 1,110.20 |
| 2013-06-30 | 648.70 |
| 2013-03-31 | 235.30 |
| 2012-12-31 | 1,737.20 |
| 2012-09-30 | 1,180.30 |
| 2012-06-30 | 772.50 |
| 2012-03-31 | 326.80 |
| 2011-12-31 | 1,438.30 |
| 2011-09-30 | 880.00 |
| 2011-06-30 | 579.10 |
| 2011-03-31 | 275.80 |
| 2010-12-31 | 1,262.60 |
| 2010-09-30 | 895.10 |
| 2010-06-30 | 523.80 |
| 2010-03-31 | 295.00 |
| 2009-12-31 | 1,472.60 |
| 2009-09-30 | 1,004.40 |
| 2009-06-30 | 658.60 |
| 2009-03-31 | 310.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $159.404B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.614B | 83.49 |
| Alcon (ALC) | Switzerland | $48.032B | 31.93 |
| Edwards Lifesciences (EW) | United States | $44.155B | 28.89 |
| IDEXX Laboratories (IDXX) | United States | $38.206B | 43.91 |
| DexCom (DXCM) | United States | $31.474B | 48.65 |
| IQVIA Holdings (IQV) | United States | $26.853B | 14.86 |
| Mettler-Toledo (MTD) | United States | $22.677B | 26.97 |
| STERIS (STE) | Ireland | $22.038B | 25.20 |
| Waters (WAT) | United States | $20.727B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $11.751B | 12.77 |
| Sysmex ADR (SSMXY) | Japan | $11.664B | 0.00 |
| Penumbra (PEN) | United States | $11.352B | 89.10 |
| Globus Medical (GMED) | United States | $9.697B | 22.45 |
| Masimo (MASI) | United States | $8.800B | 36.93 |
| Teleflex (TFX) | United States | $5.431B | 8.96 |
| Glaukos (GKOS) | United States | $4.963B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.067B | 21.31 |
| TransMedics (TMDX) | United States | $3.119B | 91.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.010B | 0.00 |
| Veracyte (VCYT) | United States | $2.453B | 44.11 |
| Nihon Kohden (NHNKY) | Japan | $2.160B | 11.81 |
| LivaNova (LIVN) | United Kingdom | $1.978B | 11.97 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.751B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.116B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.026B | 5.49 |
| Artivion (AORT) | United States | $1.015B | 95.08 |
| AxoGen (AXGN) | United States | $0.763B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.74 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| SiBone (SIBN) | United States | $0.606B | 0.00 |
| RxSight (RXST) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 9.03 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.512B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.460B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.401B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 19.63 |
| Semler Scientific (SMLR) | United States | $0.322B | 6.84 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| 908 Devices (MASS) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 10.18 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.34 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |